BioLineRx (BLRX) Intangibles (2011 - 2026)
BioLineRx (BLRX) recorded Intangibles of $16.33 million in the quarter ended Jun 30, 2026, up 56.9% from $10.41 million a year earlier but down 0.1% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Intangibles (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx reported Intangibles of $16.37 million, up 56.6% from the prior year.
- Annual Intangibles has a five-year compound annual growth rate of -5.5% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Intangibles came in at $10.45 million in the year ended Dec 31, 2024 (-29.7%), $14.85 million in the year ended Dec 31, 2023 (-32.1%), $21.89 million in the year ended Dec 31, 2022 (+0.8%) and $21.7 million in the year ended Dec 31, 2021 (unchanged).
- Quarterly Intangibles has ranged from $10.39 million in the quarter ended Sep 30, 2025 to $22.03 million in the quarter ended Sep 30, 2023 over the past five years.
- On a year-over-year basis, Intangibles has increased for three consecutive quarters, with growth averaging 3.6% over the last eight quarters.
- Peak year-over-year performance for Intangibles in the last five years was growth of 56.9% in the quarter ended Jun 30, 2026, against a decline of 39.9% in the quarter ended Sep 30, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.35 million (quarter ended Mar 31, 2026), $16.37 million (quarter ended Dec 31, 2025) and $10.39 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | BioLineRx | 6.16 Bn | 6.16 Bn | 235,000.00 | 16.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.33 Mn |
| Mar 31, 2026 | 16.35 Mn |
| Dec 31, 2025 | 16.37 Mn |
| Sep 30, 2025 | 10.39 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Mar 31, 2025 | 10.43 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 13.25 Mn |
| Jun 30, 2024 | 13.69 Mn |
| Mar 31, 2024 | 14.19 Mn |
| Dec 31, 2023 | 14.85 Mn |
| Sep 30, 2023 | 22.03 Mn |
| Jun 30, 2023 | 22.01 Mn |
| Mar 31, 2023 | 21.96 Mn |
| Dec 31, 2022 | 21.89 Mn |
| Sep 30, 2022 | 21.72 Mn |
| Jun 30, 2022 | 21.70 Mn |
| Mar 31, 2022 | 21.70 Mn |
| Dec 31, 2021 | 21.70 Mn |
| Sep 30, 2021 | 21.71 Mn |
API Access
BioLineRx Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();